CVKD

NASDAQStock

Cadrenal Therapeutics, Inc. Common Stock

$7.50+0.32 (+4.46%)

52-Week Range

$4.91

$19.87

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.07

Volume

23.0K

Avg Volume

55.6K

Performance

+29.72%

-41.58%

-46.22%

YTD

-2.05%

-63.87%

-67.92%

-88.38%

Price Chart

ETF Exposure

CVKD is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.00%	3,618	$28K	$1.27B	0.60%
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	914	$7K	$1.87B	0.15%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	1	$15	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	58	$550	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$2	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	33,278	$231K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	175	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	15	$142	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	11,923	$83K	$84.10B	0.05%

About CVKD ETF Exposure

Cadrenal Therapeutics, Inc. Common Stock (CVKD) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $7.50. Investors can gain exposure to CVKD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CVKD, sorted by portfolio weight.